8 research outputs found
Establishing cost-effectiveness of genetic targeting of cancer therapies\ud
Get PDFThe clinical benefit of a new genomic instrument, the 70-gene signature\ud
for breast cancer patients, is being evaluated in a randomised clinical\ud
trial. The early, controlled implementation process is supported by a\ud
Constructive Technology Assessment to help decision-making in an\ud
uncertain time of developmen
Establishing cost-effectiveness of genetic targeting of cancer therapies
Get PDFThe clinical benefit of a new genomic instrument, the 70-gene signature for breast cancer patients, is being evaluated in a randomised clinical trial. The early, controlled implementation process is supported by a Constructive Technology Assessment to help decision-making in an uncertain time of development
The role of FDG PET/CT in patients with locoregional breast cancer recurrence: A comparison to conventional imaging techniques
Full text link7. The yield of an intensive follow-up programme for women at increased risk for breast cancer
No full text
77. Optimal loco-regional control in larger breast cancer with modified radical mastectomy and selective use of adjuvant radiotherapy
No full text
